T1	Age 2 13	20-year-old
T2	Sex 14 18	male
T3	History 24 39	cystic fibrosis
T4	Clinical_event 44 55	transferred
E1	Clinical_event:T4 
T5	Nonbiological_location 59 85	Houston Methodist Hospital
R1	MODIFY Arg1:T5 Arg2:E1	
T6	Date 89 101	January 2013
E2	Date:T6 
T7	Clinical_event 108 117	evaluated
E3	Clinical_event:T7 
T8	Therapeutic_procedure 138 148	transplant
E4	Therapeutic_procedure:T8 
T9	Biological_structure 131 137	kidney
T10	Biological_structure 122 126	lung
T11	Disease_disorder 327 351	pancreatic insufficiency
E5	Disease_disorder:T11 
T12	Sign_symptom 327 351	pancreatic insufficiency
E6	Sign_symptom:T12 
T13	Disease_disorder 483 505	respiratory infections
E7	Disease_disorder:T13 
T14	Medication 973 982	meropenem
E8	Medication:T14 
R2	MODIFY Arg1:T10 Arg2:E4	
R3	MODIFY Arg1:T9 Arg2:E4	
T15	History 327 351	pancreatic insufficiency
T16	Therapeutic_procedure 359 374	transplantation
E9	Therapeutic_procedure:T16 
T17	Biological_structure 353 358	liver
R4	MODIFY Arg1:T17 Arg2:E9	
T18	Date 378 382	2004
E10	Date:T18 
T19	History 353 382	liver transplantation in 2004
T20	Disease_disorder 400 408	diabetes
E11	Disease_disorder:T20 
T21	Medication 384 391	steroid
E12	Medication:T21 
R5	CAUSE Arg1:E12 Arg2:E11	
T22	History 384 408	steroid-induced diabetes
T23	Disease_disorder 410 433	end-stage renal disease
E13	Disease_disorder:T23 
T24	History 410 433	end-stage renal disease
T25	Disease_disorder 439 456	testicular cancer
E14	Disease_disorder:T25 
T26	History 439 456	testicular cancer
T27	History 483 563	respiratory infections with several multidrug-resistant bacteria, including MRSA
T28	Disease_disorder 559 563	MRSA
E15	Disease_disorder:T28 
T29	Disease_disorder 519 547	multidrug-resistant bacteria
E16	Disease_disorder:T29 
R6	CAUSE Arg1:E16 Arg2:E7	
R7	CAUSE Arg1:E15 Arg2:E7	
T30	Medication 585 596	ceftaroline
E17	Medication:T30 
T31	Nonbiological_location 603 619	outside hospital
R8	MODIFY Arg1:T31 Arg2:E17	
T32	Clinical_event 641 649	transfer
E18	Clinical_event:T32 
T33	Nonbiological_location 653 679	Houston Methodist Hospital
R9	MODIFY Arg1:T33 Arg2:E18	
T34	Clinical_event 710 722	hospitalized
E19	Clinical_event:T34 
T35	Frequency 697 709	periodically
R10	MODIFY Arg1:T35 Arg2:E19	
T36	Duration 728 748	January to July 2013
E20	Duration:T36 
T37	Disease_disorder 812 822	infections
E21	Disease_disorder:T37 
T38	Detailed_description 795 811	catheter-related
T39	Biological_structure 779 790	respiratory
R11	MODIFY Arg1:T38 Arg2:E21	
R12	MODIFY Arg1:T39 Arg2:E21	
T40	Disease_disorder 833 837	MRSA
E22	Disease_disorder:T40 
R13	CAUSE Arg1:E22 Arg2:E21	
T41	Disease_disorder 842 884	multidrug-resistant Pseudomonas aeruginosa
E23	Disease_disorder:T41 
R14	CAUSE Arg1:E23 Arg2:E21	
T42	Medication 890 900	antibiotic
E24	Medication:T42 
T43	Medication 984 995	ceftazidime
E25	Medication:T43 
T44	Medication 997 1008	doxycycline
E26	Medication:T44 
T45	Medication 1010 1020	vancomycin
E27	Medication:T45 
T46	Medication 1022 1031	linezolid
E28	Medication:T46 
T47	Medication 1033 1041	cefepime
E29	Medication:T47 
T48	Medication 1043 1056	ciprofloxacin
E30	Medication:T48 
T49	Medication 1083 1091	colistin
E31	Medication:T49 
T50	Medication 1096 1106	tobramycin
E32	Medication:T50 
T51	Administration 1062 1069	inhaled
T52	Administration 1074 1082	systemic
R15	MODIFY Arg1:T52 Arg2:E31	
R16	MODIFY Arg1:T52 Arg2:E32	
R17	MODIFY Arg1:T51 Arg2:E31	
R18	MODIFY Arg1:T51 Arg2:E32	
T53	Clinical_event 1128 1138	readmitted
E33	Clinical_event:T53 
T54	Nonbiological_location 1146 1154	hospital
R19	MODIFY Arg1:T54 Arg2:E33	
T55	Date 1158 1167	June 2013
E34	Date:T55 
T56	Disease_disorder 1169 1173	MRSA
E35	Disease_disorder:T56 
T57	Diagnostic_procedure 1189 1197	cultures
E36	Diagnostic_procedure:T57 
T58	Biological_structure 1201 1206	blood
T59	Biological_structure 1211 1232	respiratory specimens
R20	MODIFY Arg1:T59 Arg2:E36	
R21	MODIFY Arg1:T58 Arg2:E36	
T60	Coreference 1244 1252	isolates
E37	Coreference:T60 
R22	IDENTICAL Arg1:E37 Arg2:E36	
T61	Diagnostic_procedure 1271 1282	clindamycin
E38	Diagnostic_procedure:T61 
#1	AnnotatorNotes E38	Note that these are diagnostics here because they are being tested for resistance, not being administered to the patient
T62	Diagnostic_procedure 1284 1293	linezolid
E39	Diagnostic_procedure:T62 
T63	Diagnostic_procedure 1295 1304	oxacillin
E40	Diagnostic_procedure:T63 
T64	Diagnostic_procedure 1310 1339	trimethoprim-sulfamethoxazole
E41	Diagnostic_procedure:T64 
T65	Diagnostic_procedure 1386 1396	vancomycin
E42	Diagnostic_procedure:T65 
T66	Diagnostic_procedure 1372 1380	rifampin
E43	Diagnostic_procedure:T66 
T67	Diagnostic_procedure 1359 1370	minocycline
E44	Diagnostic_procedure:T67 
T68	Lab_value 1344 1355	susceptible
R23	MODIFY Arg1:T68 Arg2:E44	
R24	MODIFY Arg1:T68 Arg2:E43	
R25	MODIFY Arg1:T68 Arg2:E42	
T69	Lab_value 1258 1267	resistant
R26	MODIFY Arg1:T69 Arg2:E38	
R27	MODIFY Arg1:T69 Arg2:E39	
R28	MODIFY Arg1:T69 Arg2:E40	
R29	MODIFY Arg1:T69 Arg2:E41	
T70	Diagnostic_procedure 1408 1415	isolate
E45	Diagnostic_procedure:T70 
T71	Biological_structure 1402 1407	blood
R30	MODIFY Arg1:T71 Arg2:E45	
T72	Diagnostic_procedure 1444 1467	ceftaroline Etest strip
E46	Diagnostic_procedure:T72 
T73	Lab_value 1416 1432	grew confluently
T74	Lab_value 1481 1500	MIC of >32 mg/liter
R31	MODIFY Arg1:T73 Arg2:E46	
R32	MODIFY Arg1:T74 Arg2:E46	
R33	SUB_PROCEDURE Arg1:E46 Arg2:E45	
T75	Diagnostic_procedure 1546 1554	isolates
E47	Diagnostic_procedure:T75 
T76	Biological_structure 1528 1545	respiratory tract
R34	MODIFY Arg1:T76 Arg2:E47	
T77	Disease_disorder 1518 1527	S. aureus
E48	Disease_disorder:T77 
R35	MODIFY Arg1:E48 Arg2:E47	
T78	Lab_value 1502 1506	Five
R36	MODIFY Arg1:T78 Arg2:E47	
*	OVERLAP E1 E2 E3
R37	BEFORE Arg1:E3 Arg2:E4	
A1	POLARITY E4 UNCERTAIN
#2	AnnotatorNotes E4	This transplant may not have been done
R38	AFTER Arg1:E4 Arg2:E5	
*	OVERLAP E5 E6 E9 E10 E12 E11 E13 E14 E7 E16 E15
R39	BEFORE Arg1:E15 Arg2:E17	
R40	BEFORE Arg1:E17 Arg2:E18	
R41	BEFORE Arg1:E18 Arg2:E19	
*	OVERLAP E19 E20 E21 E22 E23 E24
R42	SUB_PROCEDURE Arg1:E8 Arg2:E24	
R43	SUB_PROCEDURE Arg1:E25 Arg2:E24	
R44	SUB_PROCEDURE Arg1:E26 Arg2:E24	
R45	SUB_PROCEDURE Arg1:E27 Arg2:E24	
R46	SUB_PROCEDURE Arg1:E28 Arg2:E24	
R47	SUB_PROCEDURE Arg1:E29 Arg2:E24	
R48	SUB_PROCEDURE Arg1:E30 Arg2:E24	
R49	SUB_PROCEDURE Arg1:E31 Arg2:E24	
R50	SUB_PROCEDURE Arg1:E32 Arg2:E24	
R51	BEFORE Arg1:E24 Arg2:E33	
*	OVERLAP E33 E34 E35 E36 E37 E38 E39 E40 E41 E44 E43 E42 E45 E46 E48 E47
